DOLSTEN MIKAEL received a stock award from APELLIS PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/3/2026ACC: 0001492422-26-000092
Director
Since Mar 2026
+38.45K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
38.45K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+14.31K
Price / share
—
Trade value
—
% of position
New position
2/27/2026
0.00→14.31K
Total
Net shares
+14.31K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/27/2026 | A · Award | +14.31K | — | — | New position | 0.00 | 14.31K |
| Total | +14.31K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
24.14K shares
Shares
+24.14K
Strike price
20.96
Held after
24.14K
Exercisable
—
2/27/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock24.14K shares | 2/27/2026 | A · Award | +24.14K | 20.96 | — | 24.14K |